{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:46:56Z","timestamp":1791391616952,"version":"4.3.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11916-024-01322-7","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T02:45:52Z","timestamp":1738118752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pain\u00a0and Headache in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease"],"prefix":"10.1007","volume":"29","author":[{"given":"Paulina","family":"Diaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Nealon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike W.","family":"Kaunzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"issue":"9","key":"1322_CR1","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S1474-4422(21)00218-0","volume":"20","author":"R Marignier","year":"2021","unstructured":"Marignier R, Hacohen Y, Cobo-Calvo A, Probstel AK, Aktas O, Alexopoulos H, et al. Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. 2021;20(9):762\u201372. https:\/\/doi.org\/10.1016\/S1474-4422(21)00218-0.","journal-title":"Lancet Neurol."},{"issue":"6","key":"1322_CR2","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1093\/brain\/awac480","volume":"146","author":"R Cortese","year":"2023","unstructured":"Cortese R, Battaglini M, Prados F, Bianchi A, Haider L, Jacob A, et al. Clinical and MRI measures to identify non-acute MOG-antibody disease in adults. Brain. 2023;146(6):2489\u2013501. https:\/\/doi.org\/10.1093\/brain\/awac480.","journal-title":"Brain."},{"issue":"4","key":"1322_CR3","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1212\/CON.0000000000001127","volume":"28","author":"E Longbrake","year":"2022","unstructured":"Longbrake E. Myelin oligodendrocyte glycoprotein-associated disorders. Continuum (Minneap Minn). 2022;28(4):1171\u201393. https:\/\/doi.org\/10.1212\/CON.0000000000001127.","journal-title":"Continuum (Minneap Minn)."},{"issue":"13","key":"1322_CR4","doi-asserted-by":"publisher","first-page":"e1376","DOI":"10.1212\/WNL.0000000000207478","volume":"101","author":"L Cacciaguerra","year":"2023","unstructured":"Cacciaguerra L, Redenbaugh V, Chen JJ, Morris P, Sechi E, Syc-Mazurek SB, et al. Timing and predictors of T2-lesion resolution in patients with myelin oligodendrocyte glycoprotein antibody-associated disease. Neurology. 2023;101(13):e1376\u201381. https:\/\/doi.org\/10.1212\/WNL.0000000000207478.","journal-title":"Neurology."},{"key":"1322_CR5","doi-asserted-by":"publisher","first-page":"1137998","DOI":"10.3389\/fneur.2023.1137998","volume":"14","author":"O Corbali","year":"2023","unstructured":"Corbali O, Chitnis T. Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease. Front Neurol. 2023;14:1137998. https:\/\/doi.org\/10.3389\/fneur.2023.1137998.","journal-title":"Front Neurol."},{"key":"1322_CR6","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3389\/fneur.2020.00778","volume":"11","author":"S Asseyer","year":"2020","unstructured":"Asseyer S, Cooper G, Paul F. Pain in NMOSD and MOGAD: a systematic literature review of pathophysiology, symptoms, and current treatment strategies. Front Neurol. 2020;11:778. https:\/\/doi.org\/10.3389\/fneur.2020.00778.","journal-title":"Front Neurol."},{"issue":"9","key":"1322_CR7","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s00415-017-8583-z","volume":"264","author":"A Cobo-Calvo","year":"2017","unstructured":"Cobo-Calvo A, Ruiz A, D'Indy H, Poulat AL, Carneiro M, Philippe N, et al. MOG antibody-related disorders: common features and uncommon presentations. J Neurol. 2017;264(9):1945\u201355. https:\/\/doi.org\/10.1007\/s00415-017-8583-z.","journal-title":"J Neurol."},{"issue":"2","key":"1322_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","volume":"89","author":"S Ramanathan","year":"2018","unstructured":"Ramanathan S, Mohammad S, Tantsis E, Nguyen TK, Merheb V, Fung VSC, et al. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg Psychiatry. 2018;89(2):127\u201337. https:\/\/doi.org\/10.1136\/jnnp-2017-316880.","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"12","key":"1322_CR9","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017;140(12):3128\u201338. https:\/\/doi.org\/10.1093\/brain\/awx276.","journal-title":"Brain."},{"issue":"3","key":"1322_CR10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","volume":"22","author":"B Banwell","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023;22(3):268\u201382. https:\/\/doi.org\/10.1016\/S1474-4422(22)00431-8.","journal-title":"Lancet Neurol."},{"issue":"5","key":"1322_CR11","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1007\/s00415-018-9122-2","volume":"266","author":"R Wynford-Thomas","year":"2019","unstructured":"Wynford-Thomas R, Jacob A, Tomassini V. Neurological update: MOG antibody disease. J Neurol. 2019;266(5):1280\u20136. https:\/\/doi.org\/10.1007\/s00415-018-9122-2.","journal-title":"J Neurol."},{"issue":"1","key":"1322_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11940-019-0541-x","volume":"21","author":"Y Hacohen","year":"2019","unstructured":"Hacohen Y, Banwell B. Treatment approaches for MOG-Ab-associated demyelination in children. Curr Treat Options Neurol. 2019;21(1):2. https:\/\/doi.org\/10.1007\/s11940-019-0541-x.","journal-title":"Curr Treat Options Neurol."},{"issue":"3","key":"1322_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jamaneurol.2018.4053","volume":"76","author":"D Dubey","year":"2019","unstructured":"Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, et al. Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody. JAMA Neurol. 2019;76(3):301\u20139. https:\/\/doi.org\/10.1001\/jamaneurol.2018.4053.","journal-title":"JAMA Neurol."},{"issue":"3","key":"1322_CR14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","volume":"71","author":"J Kitley","year":"2014","unstructured":"Kitley J, Waters P, Woodhall M, Leite MI, Murchison A, George J, et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol. 2014;71(3):276\u201383. https:\/\/doi.org\/10.1001\/jamaneurol.2013.5857.","journal-title":"JAMA Neurol."},{"issue":"6","key":"1322_CR15","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/jamaneurol.2021.0912","volume":"78","author":"E Sechi","year":"2021","unstructured":"Sechi E, Buciuc M, Pittock SJ, Chen JJ, Fryer JP, Jenkins SM, et al. Positive predictive value of myelin oligodendrocyte glycoprotein autoantibody testing. JAMA Neurol. 2021;78(6):741\u20136. https:\/\/doi.org\/10.1001\/jamaneurol.2021.0912.","journal-title":"JAMA Neurol."},{"issue":"12","key":"1322_CR16","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1001\/jamaneurol.2020.3115","volume":"77","author":"AS Lopez-Chiriboga","year":"2020","unstructured":"Lopez-Chiriboga AS, Sechi E, Buciuc M, Chen JJ, Pittock SJ, Lucchinetti CF, et al. Long-term outcomes in patients with myelin oligodendrocyte glycoprotein immunoglobulin g-associated disorder. JAMA Neurol. 2020;77(12):1575\u20137. https:\/\/doi.org\/10.1001\/jamaneurol.2020.3115.","journal-title":"JAMA Neurol."},{"key":"1322_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.pediatrneurol.2024.01.026","volume":"153","author":"A Goldman-Yassen","year":"2024","unstructured":"Goldman-Yassen A, Lee A, Gombolay G. Leptomeningeal enhancement in pediatric anti-myelin oligodendrocyte glycoprotein antibody disease, multiple sclerosis, and neuromyelitis optica spectrum disorder. Pediatr Neurol. 2024;153:125\u201330. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2024.01.026.","journal-title":"Pediatr Neurol."},{"key":"1322_CR18","doi-asserted-by":"publisher","first-page":"1152235","DOI":"10.3389\/fimmu.2023.1152235","volume":"14","author":"L Li","year":"2023","unstructured":"Li L, Liu W, Cai Q, Liu Y, Hu W, Zuo Z, et al. Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images. Front Immunol. 2023;14:1152235. https:\/\/doi.org\/10.3389\/fimmu.2023.1152235.","journal-title":"Front Immunol."},{"issue":"1","key":"1322_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/jnnp-2023-331137","volume":"95","author":"P Elsbernd","year":"2023","unstructured":"Elsbernd P, Cacciaguerra L, Krecke KN, Chen JJ, Gritsch D, Lopez-Chiriboga AS, et al. Cerebral enhancement in MOG antibody-associated disease. J Neurol Neurosurg Psychiatry. 2023;95(1):14\u20138. https:\/\/doi.org\/10.1136\/jnnp-2023-331137.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"1322_CR20","doi-asserted-by":"publisher","first-page":"577653","DOI":"10.1016\/j.jneuroim.2021.577653","volume":"358","author":"GY Gombolay","year":"2021","unstructured":"Gombolay GY, Gadde JA. Aseptic meningitis and leptomeningeal enhancement associated with anti-MOG antibodies: a review. J Neuroimmunol. 2021;358:577653. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577653.","journal-title":"J Neuroimmunol."},{"issue":"10","key":"1322_CR21","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1007\/s00415-017-8615-8","volume":"264","author":"D Biotti","year":"2017","unstructured":"Biotti D, Bonneville F, Tournaire E, Ayrignac X, Dalliere CC, Mahieu L, et al. Optic neuritis in patients with anti-MOG antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France. J Neurol. 2017;264(10):2173\u20135. https:\/\/doi.org\/10.1007\/s00415-017-8615-8.","journal-title":"J Neurol."},{"issue":"1","key":"1322_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12974-016-0719-z","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Kleiter I, Ruprecht K, Asgari N, Pitarokoili K, Borisow N, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: brainstem involvement - frequency, presentation and outcome. J Neuroinflammation. 2016;13(1):281. https:\/\/doi.org\/10.1186\/s12974-016-0719-z.","journal-title":"J Neuroinflammation"},{"key":"1322_CR23","doi-asserted-by":"publisher","first-page":"642272","DOI":"10.3389\/fimmu.2021.642272","volume":"12","author":"A Marchionatti","year":"2021","unstructured":"Marchionatti A, Hansel G, Avila GU, Sato DK. Detection of MOG-IgG in clinical samples by live cell-based assays: performance of immunofluorescence microscopy and flow cytometry. Front Immunol. 2021;12:642272. https:\/\/doi.org\/10.3389\/fimmu.2021.642272.","journal-title":"Front Immunol"},{"key":"1322_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jneuroim.2017.01.007","volume":"305","author":"L Zhou","year":"2017","unstructured":"Zhou L, Huang Y, Li H, Fan J, Zhangbao J, Yu H, et al. MOG-antibody associated demyelinating disease of the CNS: a clinical and pathological study in Chinese Han patients. J Neuroimmunol. 2017;305:19\u201328. https:\/\/doi.org\/10.1016\/j.jneuroim.2017.01.007.","journal-title":"J Neuroimmunol"},{"key":"1322_CR25","doi-asserted-by":"publisher","first-page":"101965","DOI":"10.1016\/j.msard.2020.101965","volume":"40","author":"S Asseyer","year":"2020","unstructured":"Asseyer S, Hamblin J, Messina S, Mariano R, Siebert N, Everett R, et al. Prodromal headache in MOG-antibody positive optic neuritis. Mult Scler Relat Disord. 2020;40:101965. https:\/\/doi.org\/10.1016\/j.msard.2020.101965.","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"1322_CR26","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1177\/1352458515593406","volume":"22","author":"S Ramanathan","year":"2016","unstructured":"Ramanathan S, Prelog K, Barnes EH, Tantsis EM, Reddel SW, Henderson AP, et al. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler. 2016;22(4):470\u201382. https:\/\/doi.org\/10.1177\/1352458515593406.","journal-title":"Mult Scler"},{"key":"1322_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","volume":"195","author":"JJ Chen","year":"2018","unstructured":"Chen JJ, Flanagan EP, Jitprapaikulsan J, Lopez-Chiriboga ASS, Fryer JP, Leavitt JA, et al. Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome. Am J Ophthalmol. 2018;195:8\u201315. https:\/\/doi.org\/10.1016\/j.ajo.2018.07.020.","journal-title":"Am J Ophthalmol."},{"issue":"10","key":"1322_CR28","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.ophtha.2019.04.042","volume":"126","author":"H Ishikawa","year":"2019","unstructured":"Ishikawa H, Kezuka T, Shikishima K, Yamagami A, Hiraoka M, Chuman H, et al. Epidemiologic and clinical characteristics of optic neuritis in Japan. Ophthalmology. 2019;126(10):1385\u201398. https:\/\/doi.org\/10.1016\/j.ophtha.2019.04.042.","journal-title":"Ophthalmology."},{"issue":"10","key":"1322_CR29","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1007\/s00415-019-09440-8","volume":"266","author":"A Budhram","year":"2019","unstructured":"Budhram A, Mirian A, Le C, Hosseini-Moghaddam SM, Sharma M, Nicolle MW. Unilateral cortical FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis with Seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome. J Neurol. 2019;266(10):2481\u20137. https:\/\/doi.org\/10.1007\/s00415-019-09440-8.","journal-title":"J Neurol."},{"key":"1322_CR30","doi-asserted-by":"publisher","first-page":"1044642","DOI":"10.3389\/fneur.2022.1044642","volume":"13","author":"A Budhram","year":"2022","unstructured":"Budhram A, Mirian A, Sharma M. Meningo-cortical manifestations of myelin oligodendrocyte glycoprotein antibody-associated disease: Review of a novel clinico-radiographic spectrum. Front Neurol. 2022;13:1044642. https:\/\/doi.org\/10.3389\/fneur.2022.1044642.","journal-title":"Front Neurol."},{"issue":"4","key":"1322_CR31","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/jdn.10106","volume":"81","author":"F Tian","year":"2021","unstructured":"Tian F, Liu X, Yang C, Wang B, Song Z, Zhang Y. MOG antibody-positive cerebral cortical encephalitis: Two case reports and literature review. Int J Dev Neurosci. 2021;81(4):342\u201351. https:\/\/doi.org\/10.1002\/jdn.10106.","journal-title":"Int J Dev Neurosci."},{"key":"1322_CR32","doi-asserted-by":"publisher","first-page":"103727","DOI":"10.1016\/j.msard.2022.103727","volume":"60","author":"T Yao","year":"2022","unstructured":"Yao T, Zeng Q, Xie Y, Bi F, Zhang L, Xiao B, et al. Clinical analysis of adult MOG antibody-associated cortical encephalitis. Mult Scler Relat Disord. 2022;60:103727. https:\/\/doi.org\/10.1016\/j.msard.2022.103727.","journal-title":"Mult Scler Relat Disord."},{"issue":"7","key":"1322_CR33","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1007\/s10072-023-06686-z","volume":"44","author":"M Salunkhe","year":"2023","unstructured":"Salunkhe M, Gupta P, Singh RK, Tayade K, Goel V, Agarwal A, et al. Clinical and radiological spectrum of anti-myelin oligodendrocyte glycoprotein (MOG) antibody encephalitis: single-center observational study. Neurol Sci. 2023;44(7):2475\u201389. https:\/\/doi.org\/10.1007\/s10072-023-06686-z.","journal-title":"Neurol Sci."},{"issue":"11","key":"1322_CR34","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1001\/jamaneurol.2024.2945","volume":"81","author":"N Tisavipat","year":"2024","unstructured":"Tisavipat N, Rattanathamsakul N, Salman AR, Cacciaguerra L, Pittock SJ, Flanagan EP, et al. Intracranial pressure elevation and MOGAD. JAMA Neurol. 2024;81(11):1226\u20138. https:\/\/doi.org\/10.1001\/jamaneurol.2024.2945.","journal-title":"JAMA Neurol."},{"key":"1322_CR35","doi-asserted-by":"publisher","first-page":"103127","DOI":"10.1016\/j.msard.2021.103127","volume":"54","author":"M Etemadifar","year":"2021","unstructured":"Etemadifar M, Salari M, Kargaran PK, Sigari AA, Nouri H, Etemadifar F, et al. Conus medullaris involvement in demyelinating disorders of the CNS: a comparative study. Mult Scler Relat Disord. 2021;54:103127. https:\/\/doi.org\/10.1016\/j.msard.2021.103127.","journal-title":"Mult Scler Relat Disord."},{"issue":"7","key":"1322_CR36","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1007\/s00431-023-04989-z","volume":"182","author":"Y Ichimiya","year":"2023","unstructured":"Ichimiya Y, Chong PF, Sonoda Y, Tocan V, Watanabe M, Torisu H, et al. Long-lasting pain and somatosensory disturbances in children with myelin oligodendrocyte glycoprotein antibody-associated disease. Eur J Pediatr. 2023;182(7):3175\u201385. https:\/\/doi.org\/10.1007\/s00431-023-04989-z.","journal-title":"Eur J Pediatr."},{"key":"1322_CR37","doi-asserted-by":"publisher","first-page":"1050688","DOI":"10.3389\/fimmu.2022.1050688","volume":"13","author":"X Song","year":"2022","unstructured":"Song X, Ma J. Clinical characteristics of myelin-oligodendrocyte glycoprotein antibody-positive pediatric autoimmune encephalitis without demyelination: A case series. Front Immunol. 2022;13:1050688. https:\/\/doi.org\/10.3389\/fimmu.2022.1050688.","journal-title":"Front Immunol."},{"issue":"8","key":"1322_CR38","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.braindev.2023.05.002","volume":"45","author":"N Hino-Fukuyo","year":"2023","unstructured":"Hino-Fukuyo N, Kawai E, Itoh S, Oba S, Sato Y, Abe S, et al. Myelin oligodendrocyte glycoprotein antibody-associated disease in a patient with symptoms of aseptic meningitis who achieved spontaneous remission: a case report and review of the literature. Brain Dev. 2023;45(8):456\u201361. https:\/\/doi.org\/10.1016\/j.braindev.2023.05.002.","journal-title":"Brain Dev."},{"issue":"5","key":"1322_CR39","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1111\/ene.14729","volume":"28","author":"S Asseyer","year":"2021","unstructured":"Asseyer S, Henke E, Trebst C, Hummert MW, Wildemann B, Jarius S, et al. Pain, depression, and quality of life in adults with MOG-antibody-associated disease. Eur J Neurol. 2021;28(5):1645\u201358. https:\/\/doi.org\/10.1111\/ene.14729.","journal-title":"Eur J Neurol."},{"key":"1322_CR40","doi-asserted-by":"publisher","first-page":"103017","DOI":"10.1016\/j.msard.2021.103017","volume":"52","author":"MS Kang","year":"2021","unstructured":"Kang MS, Kim MK, Kim YE, Kim JH, Kim BJ, Lee HL. Two cases of myelin oligodendrocyte glycoprotein antibody-associated disease presenting with Cauda Equina syndrome without conus myelitis. Mult Scler Relat Disord. 2021;52:103017. https:\/\/doi.org\/10.1016\/j.msard.2021.103017.","journal-title":"Mult Scler Relat Disord."},{"key":"1322_CR41","doi-asserted-by":"publisher","unstructured":"Kang H, Qiu H, Hu X, Wei S, Tao Y. Differences in neuropathic pain and radiological features between AQP4-ON, MOG-ON, and IDON. Front Pain Res (Lausanne). 2022;3:870211 https:\/\/doi.org\/10.3389\/fpain.2022.870211.","DOI":"10.3389\/fpain.2022.870211"},{"key":"1322_CR42","doi-asserted-by":"publisher","unstructured":"Rinaldi S, Davies A, Fehmi J, Beadnall HN, Wang J, Hardy TA, et al. Overlapping central and peripheral nervous system syndromes in MOG antibody-associated disorders. Neurol Neuroimmunol Neuroinflamm. 2021;8(1). https:\/\/doi.org\/10.1212\/NXI.0000000000000924.","DOI":"10.1212\/NXI.0000000000000924"},{"issue":"9","key":"1322_CR43","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1111\/dmcn.14114","volume":"61","author":"EM Tantsis","year":"2019","unstructured":"Tantsis EM, Prelog K, Alper G, Benson L, Gorman M, Lim M, et al. Magnetic resonance imaging in enterovirus-71, myelin oligodendrocyte glycoprotein antibody, aquaporin-4 antibody, and multiple sclerosis-associated myelitis in children. Dev Med Child Neurol. 2019;61(9):1108\u201316. https:\/\/doi.org\/10.1111\/dmcn.14114.","journal-title":"Dev Med Child Neurol."},{"issue":"4","key":"1322_CR44","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1177\/1352458519840747","volume":"26","author":"S Sundaram","year":"2020","unstructured":"Sundaram S, Nair SS, Jaganmohan D, Unnikrishnan G, Nair M. Relapsing lumbosacral myeloradiculitis: an unusual presentation of MOG antibody disease. Mult Scler. 2020;26(4):509\u201311. https:\/\/doi.org\/10.1177\/1352458519840747.","journal-title":"Mult Scler."},{"key":"1322_CR45","unstructured":"Rinaldi S, Con Y, Barnett M, Broadley S, Irani SR, Reddel SW et al (2019) Peripheral nervous system involvement in MOG antibody-associated demyelination."},{"issue":"4","key":"1322_CR46","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11916-017-0620-1","volume":"21","author":"A Masters-Israilov","year":"2017","unstructured":"Masters-Israilov A, Robbins MS. Headache in neuromyelitis optica. Curr Pain Headache Rep. 2017;21(4):20. https:\/\/doi.org\/10.1007\/s11916-017-0620-1.","journal-title":"Curr Pain Headache Rep."},{"issue":"2","key":"1322_CR47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10384-018-0561-1","volume":"62","author":"T Kezuka","year":"2018","unstructured":"Kezuka T, Ishikawa H. Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis. Jpn J Ophthalmol. 2018;62(2):101\u20138. https:\/\/doi.org\/10.1007\/s10384-018-0561-1.","journal-title":"Jpn J Ophthalmol."},{"issue":"6","key":"1322_CR48","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1017\/cjn.2021.28","volume":"48","author":"JD Krett","year":"2021","unstructured":"Krett JD, Jarvis SE, Alikhani K. Myelin oligodendrocyte glycoprotein antibody-associated myelitis presenting with headache. Can J Neurol Sci. 2021;48(6):879\u201381. https:\/\/doi.org\/10.1017\/cjn.2021.28.","journal-title":"Can J Neurol Sci."}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-024-01322-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-024-01322-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-024-01322-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T21:02:45Z","timestamp":1771275765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-024-01322-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1322"],"URL":"https:\/\/doi.org\/10.1007\/s11916-024-01322-7","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"10 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consen"}}],"article-number":"39"}}